These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33609732)

  • 1. Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy.
    Reschke CR; Silva LFA; Vangoor VR; Rosso M; David B; Cavanagh BL; Connolly NMC; Brennan GP; Sanz-Rodriguez A; Mooney C; Batool A; Greene C; Brennan M; Conroy RM; Rüber T; Prehn JHM; Campbell M; Pasterkamp RJ; Henshall DC
    Mol Ther; 2021 Jun; 29(6):2041-2052. PubMed ID: 33609732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus.
    Jimenez-Mateos EM; Engel T; Merino-Serrais P; Fernaud-Espinosa I; Rodriguez-Alvarez N; Reynolds J; Reschke CR; Conroy RM; McKiernan RC; deFelipe J; Henshall DC
    Brain Struct Funct; 2015 Jul; 220(4):2387-99. PubMed ID: 24874920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy.
    Reschke CR; Silva LFA; Norwood BA; Senthilkumar K; Morris G; Sanz-Rodriguez A; Conroy RM; Costard L; Neubert V; Bauer S; Farrell MA; O'Brien DF; Delanty N; Schorge S; Pasterkamp RJ; Rosenow F; Henshall DC
    Mol Ther Nucleic Acids; 2017 Mar; 6():45-56. PubMed ID: 28325299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting microRNA-134 for seizure control and disease modification in epilepsy.
    Morris G; Reschke CR; Henshall DC
    EBioMedicine; 2019 Jul; 45():646-654. PubMed ID: 31300345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonizing Increased
    Vangoor VR; Reschke CR; Senthilkumar K; van de Haar LL; de Wit M; Giuliani G; Broekhoven MH; Morris G; Engel T; Brennan GP; Conroy RM; van Rijen PC; Gosselaar PH; Schorge S; Schaapveld RQJ; Henshall DC; De Graan PNE; Pasterkamp RJ
    J Neurosci; 2019 Jun; 39(26):5064-5079. PubMed ID: 31015341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagomirs Targeting MicroRNA-134 Increase Limk1 Levels After Experimental Seizures in Vitro and in Vivo.
    Sun J; Gao X; Meng D; Xu Y; Wang X; Gu X; Guo M; Shao X; Yan H; Jiang C; Zheng Y
    Cell Physiol Biochem; 2017; 43(2):636-643. PubMed ID: 28942448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagomir-mediated suppression of microRNA-134 reduces kainic acid-induced seizures in immature mice.
    Campbell A; Morris G; Heller JP; Langa E; Brindley E; Worm J; Jensen MA; Miller MT; Henshall DC; Reschke CR
    Sci Rep; 2021 Jan; 11(1):340. PubMed ID: 33431894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade.
    Wang D; Li Z; Zhang Y; Wang G; Wei M; Hu Y; Ma S; Jiang Y; Che N; Wang X; Yao J; Yin J
    Epilepsia; 2016 May; 57(5):706-16. PubMed ID: 26945677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletion of microRNA-22 blunts the inflammatory transcriptional response to status epilepticus and exacerbates epilepsy in mice.
    Almeida Silva LF; Reschke CR; Nguyen NT; Langa E; Sanz-Rodriguez A; Gerbatin RR; Temp FR; de Freitas ML; Conroy RM; Brennan GP; Engel T; Henshall DC
    Mol Brain; 2020 Aug; 13(1):114. PubMed ID: 32825833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systems approach delivers a functional microRNA catalog and expanded targets for seizure suppression in temporal lobe epilepsy.
    Venø MT; Reschke CR; Morris G; Connolly NMC; Su J; Yan Y; Engel T; Jimenez-Mateos EM; Harder LM; Pultz D; Haunsberger SJ; Pal A; Heller JP; Campbell A; Langa E; Brennan GP; Conboy K; Richardson A; Norwood BA; Costard LS; Neubert V; Del Gallo F; Salvetti B; Vangoor VR; Sanz-Rodriguez A; Muilu J; Fabene PF; Pasterkamp RJ; Prehn JHM; Schorge S; Andersen JS; Rosenow F; Bauer S; Kjems J; Henshall DC
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15977-15988. PubMed ID: 32581127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagomirs and microRNA in status epilepticus.
    Henshall DC
    Epilepsia; 2013 Sep; 54 Suppl 6(0 6):17-9. PubMed ID: 24001063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-23a contributes to hippocampal neuronal injuries and spatial memory impairment in an experimental model of temporal lobe epilepsy.
    Zhu X; Zhang A; Dong J; Yao Y; Zhu M; Xu K; Al Hamda MH
    Brain Res Bull; 2019 Oct; 152():175-183. PubMed ID: 31336125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the pathophysiology and treatment of status epilepticus.
    Henshall DC
    Front Mol Neurosci; 2013; 6():37. PubMed ID: 24282394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects.
    Jimenez-Mateos EM; Engel T; Merino-Serrais P; McKiernan RC; Tanaka K; Mouri G; Sano T; O'Tuathaigh C; Waddington JL; Prenter S; Delanty N; Farrell MA; O'Brien DF; Conroy RM; Stallings RL; DeFelipe J; Henshall DC
    Nat Med; 2012 Jul; 18(7):1087-94. PubMed ID: 22683779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of microRNA-21-5p protects against seizure damage in a kainic acid-induced status epilepticus model via PTEN-mTOR.
    Tang C; Gu Y; Wang H; Wu H; Wang Y; Meng Y; Han Z; Gu Y; Ma W; Jiang Z; Song Y; Na M; Lu D; Lin Z
    Epilepsy Res; 2018 Aug; 144():34-42. PubMed ID: 29751355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol- and Progesterone-Associated Changes in microRNA-Induced Silencing and Reduced Antiseizure Efficacy of an Antagomir in Female Mice.
    Tiwari D; Rajathi V; Rymer JK; Beasley LN; McGann AM; Bunk AT; Parkins EV; Rice MF; Smith KE; Ritter DM; White AR; Doerning CM; Gross C
    eNeuro; 2023 Jul; 10(7):. PubMed ID: 37433683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous injection of antagomiR-1 on brain ischemia.
    Talebi A; Rahnema M; Bigdeli MR
    Mol Biol Rep; 2019 Feb; 46(1):1149-1155. PubMed ID: 30707419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as biomarkers and treatment targets in status epilepticus.
    Brindley E; Hill TDM; Henshall DC
    Epilepsy Behav; 2019 Dec; 101(Pt B):106272. PubMed ID: 31171435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of miR-146a/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy.
    He F; Liu B; Meng Q; Sun Y; Wang W; Wang C
    Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27852797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatio-temporally restricted blood-brain barrier disruption after intra-amygdala kainic acid-induced status epilepticus in mice.
    Michalak Z; Sano T; Engel T; Miller-Delaney SF; Lerner-Natoli M; Henshall DC
    Epilepsy Res; 2013 Feb; 103(2-3):167-79. PubMed ID: 23182415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.